mash and glp 1 GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated Novo Nordisk leads MASH therapeutic

While these uses arent FDA-approved, early evidence is promising and we work closely with clients who may benefit

B12 pairs well with other vitamin shots (like B Complex or Biotin) and IV drips for holistic wellness support

Recent findings demonstrate that antibiotic-induced gut dysbiosis can also reshape dendritic architecture in adult cortical interneurons (Nakhal et al., 2025a) and stellate cells in the medial entorhinal cortex (Mydeen et al., 2025)

16(2): 8182.Google ScholarPubMed Errichetti, E., De Francesco, V., Pegolo, E

While further studies are needed to confirm these benefits in larger lupus populations, the research opens the door to new possibilities

For patients exploring non-injection options: Oral semaglutide drops and tirzepatide drops are available through various providers, including Lavender Sky Strive Pharmacy sublingual option